{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:12:12Z","timestamp":1762459932017,"version":"build-2065373602"},"reference-count":38,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Hepatitis C virus (HCV)-induced inflammation contributes to progressive liver disease. The chemoattractant protein chemerin is associated with systemic inflammation. We hypothesized that chemerin is a biomarker that predicts the severity of liver disease in HCV patients. Furthermore, we investigated whether serum chemerin levels change during the course of HCV treatment using direct-acting antivirals (DAAs). Therefore, we measured serum concentration of chemerin in a cohort of 82 HCV-infected patients undergoing DAA treatment. Serum chemerin was positively associated with leukocyte count and negatively with markers of hepatic function and the model of end-stage liver disease (MELD) score. Low circulating chemerin levels significantly correlated with advanced liver fibrosis and cirrhosis as measured by the fibrosis-4 (FIB-4) score, the aminotransferase\/platelet (AST\/PLT) ratio index (APRI) score and the non-alcoholic fatty liver disease (NAFLD) score. Chemerin did not correlate with viral load or viral genotype. Treatment with DAAs did not improve MELD score and leukocyte count within the observation period, up to three months after the end of DAA treatment. Accordingly, chemerin levels remained unchanged during the treatment period. We conclude that low circulating chemerin is a noninvasive biomarker for hepatic dysfunction and advanced liver fibrosis and cirrhosis in HCV infection.<\/jats:p>","DOI":"10.3390\/diagnostics10110974","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T10:46:26Z","timestamp":1605782786000},"page":"974","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Chemerin Is a Valuable Biomarker in Patients with HCV Infection and Correlates with Liver Injury"],"prefix":"10.3390","volume":"10","author":[{"given":"Georg","family":"Peschel","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Grimm","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"G\u00fclow","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5635-3994","authenticated-orcid":false,"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kilian","family":"Weigand","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hep.20030","article-title":"Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth","volume":"39","author":"Casiraghi","year":"2004","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jvh.12035","article-title":"Hepatitis C virus diversity and hepatic steatosis","volume":"20","author":"Roingeard","year":"2013","journal-title":"J. Viral Hepat."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/hep.21239","article-title":"Impact of obesity on treatment of chronic hepatitis C","volume":"43","author":"Charlton","year":"2006","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Buechler, C., Feder, S., Haberl, E.M., and Aslanidis, C. (2019). Chemerin Isoforms and Activity in Obesity. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20051128"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1210\/en.2007-0175","article-title":"Chemerin is a novel adipokine associated with obesity and metabolic syndrome","volume":"148","author":"Bozaoglu","year":"2007","journal-title":"Endocrinology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1210\/jc.2008-1833","article-title":"Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population","volume":"94","author":"Bozaoglu","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.tem.2010.08.001","article-title":"Chemerin: At the crossroads of inflammation and obesity","volume":"21","author":"Ernst","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_8","first-page":"102","article-title":"Association of chemerin levels with anthropometric indexes and C-reactive protein in obese and non-obese adolescents","volume":"11","author":"Maghsoudi","year":"2015","journal-title":"Arya Atheroscler."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5507\/bp.2008.033","article-title":"Chemerin Is an Independent Marker of the Metabolic Syndrome in a Caucasian Population\u2014A Pilot Study","volume":"152","author":"Stejskal","year":"2008","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2265.2009.03664.x","article-title":"Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes","volume":"72","author":"Weigert","year":"2010","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cen.12363","article-title":"Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects","volume":"81","author":"Lorincz","year":"2014","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Li, Y., Shi, B., and Li, S. (2014). Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome: A meta-analysis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0113915"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.yexmp.2015.01.010","article-title":"Reduced serum chemerin in patients with more severe liver cirrhosis","volume":"98","author":"Eisinger","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9242","DOI":"10.1038\/s41598-018-27543-6","article-title":"Low circulating chemerin levels correlate with hepatic dysfunction and increased mortality in decompensated liver cirrhosis","volume":"8","author":"Horn","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yexmp.2013.07.009","article-title":"Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver","volume":"95","author":"Krautbauer","year":"2013","journal-title":"Exp. Mol. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Buechler, C., Haberl, E.M., Rein-Fischboeck, L., and Aslanidis, C. (2017). Adipokines in Liver Cirrhosis. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071392"},{"key":"ref_17","first-page":"8","article-title":"Evaluation of chemerin and leptin in serum of chronic hepatitis C patients","volume":"1","author":"Mansour","year":"2018","journal-title":"Histol. Cell Biol."},{"key":"ref_18","first-page":"661","article-title":"Chemerin, vaspin and insulin resistance in chronic hepatitis C","volume":"17","author":"Kukla","year":"2010","journal-title":"J. Viral Hepat."},{"key":"ref_19","unstructured":"European Association for the Study of the Liver (2020). Electronic address eee, Clinical Practice Guideline Panel C, Panel m, representative EGB. EASL Clinical Practice Guidelines: drug-induced liver injury. J. Hepatol., 73, 1170\u20131218."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"15074","DOI":"10.1038\/s41598-018-33536-2","article-title":"Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma","volume":"8","author":"Ho","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.6061\/clinics\/2017(09)01","article-title":"Accuracy of transient elastography-FibroScan(R), acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C","volume":"72","author":"Ragazzo","year":"2017","journal-title":"Clinics (Sao Paulo)"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/gut.2005.069757","article-title":"Steatosis in chronic hepatitis C: Why does it really matter?","volume":"55","author":"Asselah","year":"2006","journal-title":"Gut"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/hep.20982","article-title":"Viral load as a predictor of progression of chronic hepatitis C?","volume":"42","author":"Heller","year":"2005","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jhep.2020.03.031","article-title":"DAA therapy and long-term hepatic function in advanced\/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort","volume":"73","author":"Verna","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mgene.2018.07.010","article-title":"The role of chemerin and vaspin in Egyptian patients with viral hepatitis C","volume":"18","author":"Shawkey","year":"2018","journal-title":"Meta Gene"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Feder, S., Kandulski, A., Schacherer, D., Weiss, T.S., and Buechler, C. (2019). Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20163919"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.aohep.2020.04.003","article-title":"Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population?","volume":"19","author":"Foschi","year":"2020","journal-title":"Ann. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Giuffre, M., Fouraki, S., Comar, M., Masutti, F., and Croce, L.S. (2020). The Importance of Transaminases Flare in Liver Elastography: Characterization of the Probability of Liver Fibrosis Overestimation by Hepatitis C Virus-Induced Cytolysis. Microorganisms, 8.","DOI":"10.3390\/microorganisms8030348"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Giuffre, M., Fouraki, S., Campigotto, M., Colombo, A., Visintin, A., Buonocore, M.R., Aversano, A., Budel, M., Tine, F., and Abazia, C. (2020). Alanine aminotransferase and spleno-portal dynamics affect spleen stiffness measured by point shear-wave elastography in patients with chronic hepatitis C in the absence of significant liver fibrosis. J. Ultrasound.","DOI":"10.1007\/s40477-020-00456-9"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.3748\/wjg.v24.i47.5297","article-title":"Hepatitis C: From inflammatory pathogenesis to anti-inflammatory\/hepatoprotective therapy","volume":"24","author":"Li","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gastaldi, G., Gomes, D., Schneiter, P., Montet, X., Tappy, L., Clement, S., and Negro, F. (2019). Treatment with direct-acting antivirals improves peripheral insulin sensitivity in non-diabetic, lean chronic hepatitis C patients. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0217751"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"892","DOI":"10.7150\/ijms.43079","article-title":"Direct-acting Antiviral in the Treatment of Chronic Hepatitis C: Bonuses and Challenges","volume":"17","author":"Zeng","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Hashimoto, S., Yatsuhashi, H., Abiru, S., Yamasaki, K., Komori, A., Nagaoka, S., Saeki, A., Uchida, S., Bekki, S., and Kugiyama, Y. (2016). Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163644"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"170434","DOI":"10.1155\/2014\/170434","article-title":"Circulating Adipokines in Healthy versus Unhealthy Overweight and Obese Subjects","volume":"2014","author":"Alfadda","year":"2014","journal-title":"Int. J. Endocrinol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3109\/10641963.2013.827697","article-title":"Chemerin is associated with inflammatory markers and metabolic syndrome phenotypes in hypertension patients","volume":"36","author":"Gu","year":"2014","journal-title":"Clin. Exp. Hypertens."},{"key":"ref_37","first-page":"111","article-title":"CHEMERIN IS AN INDISPENSABLE PRE-TREATMENT PREDICTOR OF SOFOSBUVIR, PEGYLATED INTERFERON-ALPHA AND RIBAVIRIN OUTCOMES IN CHRONIC HEPATITIS C EGYPTIAN PATIENTS","volume":"60","author":"Marwa","year":"2019","journal-title":"Az. J. Pharm. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s13337-020-00592-0","article-title":"HCV genotypes and their determinative role in hepatitis C treatment","volume":"31","author":"Keikha","year":"2020","journal-title":"Virusdisease"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/10\/11\/974\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:34:32Z","timestamp":1760178872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/10\/11\/974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":38,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["diagnostics10110974"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics10110974","relation":{},"ISSN":["2075-4418"],"issn-type":[{"type":"electronic","value":"2075-4418"}],"subject":[],"published":{"date-parts":[[2020,11,19]]}}}